Biosero Collaborates with Scripps Research Institute to Automate Lab Screening for COVID-19 Drug Therapy Candidates

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 04/14/2020.
  • Additional Information
    • Alternate Title:
      BIOSERO-COVID-19
    • Subject Terms:
    • Abstract:
      SAN DIEGO, April 14, 2020 /PRNewswire/ -- Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates. The research team is using a custom automation platform operated by Green Button Go™ Automation Scheduling and Data Integration Software to screen 14,000 compounds that have already been approved by the FDA for therapeutic potential against COVID-19. [ABSTRACT FROM PUBLISHER]